About: Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.83 (-1.28%)
CNTB NASDAQ Connect Biopharma Holdings Ltd
Carregando status da lista de acompanhamento…
Connect Biopharma Holdings Ltd share price
Atividade de preço de CNTB
Último preço
$ 0,830
Variação (24h)
-0,01 USD (1,28%)
Volume
66.39K
Volume (média 4 sem.)
-
Abertura
$ 0,85
Variação do dia
$ 0,83 - $ 0,85
Fechamento anterior
$ 0,85
Último negócio
29 Oct, 5:52 pm GMT+0
Atrasado
29 Oct, 5:52 pm GMT+0
CNTB price performance
+9,50%
5D
-15,88%
1M
-70,41%
YTD
-47,30%
1Y
Atrasado
29 Oct, 5:52 pm GMT+0
quote.marketSignals